Download presentation
Presentation is loading. Please wait.
1
Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub}{\Sigma}}_{1... Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub}{\Sigma}}_{1}\) \end{document} (all cancer end points) and \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub{\Sigma}{-}lung}}_{1}\) \end{document} (known human lung carcinogens only) for both CSF sets I and II. The average values \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\overline{\mathrm{ILCR}}^{\mathrm{sub{\Sigma}}}_{1}\) \end{document} and \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\overline{\mathrm{ILCR}}^{\mathrm{sub{\Sigma}{-}lung}}_{1}\) \end{document} are marked. James F. Pankow et al. Cancer Epidemiol Biomarkers Prev 2007;16: ©2007 by American Association for Cancer Research
![Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub}{\Sigma}}_{1...](http://slideplayer.com./slide/17322306/100/images/1/Brand-specific+incremental+lifetime+cancer+risk+subtotals%3A+%5Cbatchmode+%5Cdocumentclass%5Bfleqn%2C10pt%2Clegalpaper%5D%7Barticle%7D+%5Cusepackage%7Bamssymb%7D+%5Cusepackage%7Bamsfonts%7D+%5Cusepackage%7Bamsmath%7D+%5Cpagestyle%7Bempty%7D+%5Cbegin%7Bdocument%7D+%5C%28%5Cmathrm%7BILCR%7D%5E%7B%5Cmathrm%7Bsub%7D%7B%5CSigma%7D%7D_%7B1....jpg "Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub}{\Sigma}}_{1}\) \end{document} (all cancer end points) and \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub{\Sigma}{-}lung}}_{1}\) \end{document} (known human lung carcinogens only) for both CSF sets I and II. The average values \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\overline{\mathrm{ILCR}}^{\mathrm{sub{\Sigma}}}_{1}\) \end{document} and \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\overline{\mathrm{ILCR}}^{\mathrm{sub{\Sigma}{-}lung}}_{1}\) \end{document} are marked. James F. Pankow et al. Cancer Epidemiol Biomarkers Prev 2007;16: ©2007 by American Association for Cancer Research.")
Similar presentations
![Figure 2. Isopleths for dose rate (top) and fluence rate (bottom) as function of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb}](/72/12258051/big_thumb.jpg "Figure 2. Isopleths for dose rate (top) and fluence rate (bottom) as function of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb}>")
![Fig. 1. SA-induced the generation of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath}](/86/13965010/big_thumb.jpg "Fig. 1. SA-induced the generation of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath}>")
